/ Research Lines

Cell Signalling, Epidemiology, Clinic and Cancer Therapy Group

Main achievements


1. Identification of diagnostic/prognostic and drug response biomarkers are group contributions: oxidative stress and DNA methylation are complementary prognostic biomarkers in myelodysplastic syndromes (MDS) patients; plasmatic peroxides levels are good predictive biomarkers of response to erythropoiesis-stimulating agents in lower-risk MDS; drug transporters variants as good susceptibility and prognostic biomarkers in chronic myeloid leukemia (CML) and the hydropathy index of the HCDR3 sequences of chronic lymphocytic leukemia (CLL) cells allows the identification of a subgroup of CLL patients with intermediate prognostic features. Moreover, Blood-based specimens may be potential source of non-invasive DNA methylation cancer biomarkers in MDS.

2. The assessment of different immune cells’ status in neoplasias context revealed the impact of an immunosuppressive state on patients’ stratifications, prognosis, and therapy monitoring.

3. Evaluation of therapeutic potential of new compounds in different neoplasias to improve or overcome lack of response of current approaches

4. In the context of international networking, reviews in high-impact journals were published focused on therapy resistance, the impact of metabolism and hypoxia in cancer, the role of immune system in cancer prognosis and monitoring, the molecular mechanisms of tyrosine kinase inhibitors resistance in CML and the elaboration of international (European) guidelines/consensus on cancer (mainly dermatological) and skink allergic diseases.

Publications

Scientific interests and ongoing research projects


1. canSERV (Providing cutting edge cancer research services across Europe). IR: EATRIS. Particiapnts: Laranjeira P, Paiva A. Funding: European Comission HORIZON-INFRA-2021-SERV-01. 2021.

2. Clinical relevance of platelets as non-invasive biomarkers in diffuse large B-cell lymphoma – A pilot study. Coordinator: Sarmento Ribeiro AB. Participants: Gonçalves AC, Lapa B, Jorge J, Alves R, Geraldes C, Cortesão E, Carda JP. Funding: LPCC-NRC/CIMAGO, SPH 2021-2023.

CuidIn - Apoiar e Cuidar do Cuidador Informal (N/Ref.ª: 3695/POISE/EMPIS/SI/3.33/2020). Coordinators: Dourado M and Ferreira P. Funding: Portugal 2020/ POISE-03-4639-EU-FSE-000765. 2020-2023.

3. Eventos adversos imunológicos dos inibidores dos “check-point” imunológicos – estudo dos seus fenótipos e biomarcadores. Coordinator: Gonçalo M. Funding: FMUC- PEPITA. 2019-2022.

4. New diagnostic and therapeutic tools against multidrug resistant tumors - COST action CA17104. PI: Chiara Riganti (U Turin, Italy). Participant: Sarmento Ribeiro AB, Gonçalves AC, Alves R. Funding: European Comission-COST. 2018-2022.

5. Radiolabeled EXosomes - a nanotheranostic tool for lung micrometastasis in osteosarcoma. (PTDC/BTM-SAL/4451/2020). Coordinator: Gomes C. Funding: FCT. 2021-2023.

6. Red Transfronteriza de Innovación en Diagnóstico Precoz de Leucemia para un envejecimiento saludable – IDIAL-NET. Coordinators: Orfão A. and Sarmento Ribeiro AB. Funding: Interreg-POCTEP 2019-2022

Team

Group Leader

Ana Bela Sarmento Ribeiro

PhD Members

AM
Adélia Simão, MD
AM
Ana Bela Sarmento Ribeiro, MD
AG
Ana Cristina Gonçalves
AM
António Bernardes, MD
AP
Artur Paiva
BM
Belmiro Parada, MD
CM
Catarina Geraldes, MD
CG
Célia Gomes
EM
Emília Cortesão, MD
JM
José Casanova, MD
LM
Luís Semedo, MD
MM
Margarida Gonçalo, MD
MD
Maria Manuel Donato
MM
Marília Dourado, MD
PM
Paulo Donato, MD
PL
Paula Laranjeira
RA
Raquel Alves
RM
Ricardo Vieira, MD
SM
Sara Duarte, MD
VM
Vitor Rodrigues, MD
VM
Vitor Sousa, MD

PhD Students

AS
Ana Isabel Sebastião
AM
André Lazaro, MD
BM
Bárbara Marques, MD
BL
Beatriz Lapa
CM
Carla Diogo, MD
CM
Catarina Melo, MD
CM
Catarina Quintas, MD
CD
Cátia Domingues
DR
Diana Rodrigues
DM
Diogo Moura, MD
EM
Edgar Pratas, MD
CM
Catarina Melo, MDFrederico Furriel, MD
GR
Gabriela Ribeiro
HM
Hugo Ribeiro, MD
IC
Inês Costa
IM
Inês Gois, MD
IM
Isabel Ferreira, MD
IH
Ivanna Hrynchak
JM
Joana Azevedo, MD
JJ
Joana Jorge
JM
João Paulo Freitas, MD
JM
João Pedro Oliveira, MD
LS
Liliana Santos
MC
Margarida Coucelo
MM
Mário Lourenço, MD
MM
Marta Pereira, MD
RM
Rita Canário, MD
RM
Ruben Fonseca, MD